CTT Named 'Best Clinical Trial Site' by World Vaccine Congress

b'SAN ANTONIO, May 13, 2021 /PRNewswire-PRWeb/ -- Clinical Trials of Texas, Inc. (CTT) was named "Best Clinical Site" at the 14th annual Vaccine Industry Excellence (ViE) Awards during the 2021 World Vaccine Congress.\n"CTT is so honored to be recognized for its vaccine work alongside some of the most prestigious names in the pharmaceutical industry," said President/CEO Kay Scroggins, RN.\nCTT has conducted more than 40 vaccine trials including COVID-19, Influenza, Pneumonia, RSV and Meningitis.